Orbimed Advisors - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$11,811,000
-26.2%
13,421,283
+4.0%
0.21%
-17.7%
Q1 2022$16,008,000
-36.4%
12,909,2830.0%0.26%
-19.8%
Q4 2021$25,173,000
-28.8%
12,909,2830.0%0.32%
-16.7%
Q3 2021$35,371,000
-22.4%
12,909,283
-10.8%
0.39%
-15.6%
Q2 2021$45,574,000
+148.7%
14,467,872
+68.2%
0.46%
+169.6%
Q1 2021$18,327,000
+26.0%
8,604,000
+14.7%
0.17%
+34.6%
Q4 2020$14,550,0007,500,0000.13%
Other shareholders

There were no reported owners of VISTAGEN THERAPEUTICS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of VISTAGEN THERAPEUTICS INC shareholders